Koyfin Home > Directory > Health Care > Amphastar Pharma > Total Debt / EBITDA

Amphastar Pharma Total Debt / EBITDA Chart (AMPH)

Amphastar Pharma annual/quarterly Total Debt / EBITDA from 2014 to 2018.
  • Amphastar Pharma Total Debt / EBITDA for the quarter ending December 12, 2018 was $2m a -149.34% decrease of -3m year over year
  • Amphastar Pharma Total Debt / EBITDA for the last 12 months ending December 12, 2018 was $7m a 40.34% increase of 3m year over year
  • Amphastar Pharma Annual Total Debt / EBITDA for 2018 was $7m a 38.28% increase of 3m from 2017
  • Amphastar Pharma Annual Total Debt / EBITDA for 2017 was $4m a 69.99% increase of 3m from 2016
  • Amphastar Pharma Annual Total Debt / EBITDA for 2016 was $1m a -245.98% decrease of -3m from 2015
Other Ratios Metrics:
  • Amphastar Pharma Total Debt / Capital for the quarter ending December 12, 2018 was $12m a -1.34% decrease of 0m year over year
  • Amphastar Pharma Other Liabilities for the quarter ending December 12, 2018 was $10m a -0.42% decrease of 0m year over year
  • Amphastar Pharma Total Debt / Equity for the quarter ending December 12, 2018 was $14m a -1.53% decrease of 0m year over year
View Chart On Koyfin

Quarterly AMPH Total Debt / EBITDA Data

12/2018$2m
09/2018$2m
06/2018$11m
12/2017$6m
09/2017$10m
06/2017$2m
03/2017$4m
09/2016$1m
06/2016$1m
03/2016$1m

Annual AMPH Total Debt / EBITDA Data

2018$7m
2017$4m
2016$1m
2015$4m
2013$1m